US 12421251
Cystic fibrosis transmembrane conductance regulator modulating agents
granted A61PA61P11/00
Quick answer
US patent 12421251 (Cystic fibrosis transmembrane conductance regulator modulating agents) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P11/00